This Viewpoint discusses the risks and benefits of antimicrobial use, an approach to decision making in prescribing antimicrobials, and the next steps in improving infection management for patients at the end of life.
No takes yet. Share an insight, caveat, or question.
Juthani‐Mehta et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: